About our product, Mycosinate™
Nektr Technologies have completed its Phase II/III Pharmaceutical clinical trial against the European market leader with outstanding results.
Nektr’s breakthrough Technology, Mycosinate™ has succeeded in outperforming the European market leader by over 5x in reducing infected area of the nail.
What is Onychomycosis?
The prevalence of Onychomycosis, commonly known as fungal nail infection, increases steadily with age and is present in 50-60% of people over the age of 60 . This condition is caused by the dermatophyte Trichophyton rubrum and associated pathogens.
Present fungal nail treatments are broadly ineffective due to a number of factors. Mycosinate® with its low molecular weight has demonstrated a very successful pathway to deliver the lethal payload to the source of the infection.
Why Do Topical Antifungals Fail to Cure Fungal Nail Infection?
Why Mycological Cure is a False Indicator of Clinical Success
Figure 1: Difference between Treatment A (Mycosinate) and Treatment B (5% Amorolfine) in percentage change in clear healthy nail area.
Figure 2: Mycosinate average area of infection trends
Rapid improvement leads to patient satisfaction
Mycosinate® with its low molecular weight has demonstrated a very successful pathway to deliver the lethal payload to the source of the infection.
Click on the slider and drag from left to right to view the improvement after three weeks of treatment.
– Before treatment & after Three weeks treatment
After only three weeks of treatment with Mycosinate® there is substantial improvement in the infected nail visually looking better and a reduced infected area.
Before T=0 After T=3 weeks
Plans for the Future
Nektr Technologies are presently seeking third parties to commercialise Mycosinate.
Our summary proposal document of the Mycosinate opportunity is available below.
Do you have questions about Nektr or our technology? Connect with us using the details below or get in touch by filling out the form We would be happy to answer your questions!
Finisklin Business & Technology Park,
Sligo, Ireland, F91 HF66